Where three defendant high-level employees of a dialysis services company have moved to dismiss a complaint brought by the Securities and Exchange Commission, that motion should be denied despite the defendants’ contention that the complaint fails to allege that they substantially participated in a fraudulent scheme with the requisite scienter. “This case arises out of
Three former financial executives of dialysis company American Renal Associates Holdings Inc. must face U.S. Securities and Exchange Commission claims they cooked the company's books by more than $39 million in 2017 and 2018, a Boston federal judge has determined.
Last week, the SEC announced settled charges against Gentex Corporation, a manufacturer of digital vision, connected car, dimmable glass and fire protection products.
Just in time for the holidays cookie jars full of…revenue adjustments! In this complaint, the SEC charged American Renal Associates Holdings, Inc., a national provider of dialysis.